Autopsy report · NCT02943837

EUS-guided Fine Needle Aspiration (EUS-FNA) Versus EUS-guided Fine Needle Biopsy (EUS-FNB) for Diagnosis of Subepithelial Tumors

“Funding issues”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Asan Medical Center

Sponsor type

University, hospital or other

Conditions

Gastrointestinal Subepithelial Tumors

Interventions

Device: 22G FNA needle; Device: 20G FNB needle

Participants

0

Trials that died the same way

• Acetaminophen to Prevent Ischemic Oxidative Reperfusion Injury During Percutaneous Coronary Intervention for Acute Myocardial Infarction
  “Funding issue” (93% match in meaning)
• Biodentine Partial Pulpotomy of Pulpally Exposed Primary Molars
  “technical and funding issues” (85% match in meaning)
• Cannabinoids for Taxane Induced Peripheral Neuropathy
  “Funding being sought” (81% match in meaning)
• A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis
  “Funding constraints” (81% match in meaning)
• Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment
  “Inadequate funding” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.